Skip to main content

Valproate Sodium Injection Shortage

Last Updated: July 12, 2019
Status: Resolved

Products Affected - Description
    • Depacon injection, AbbVie, 100 mg/mL, 5 mL vial, 10 count, NDC 00074-1564-10 - discontinued
Reason for the Shortage
    • Abbvie discontinued Depacon in May 2019.
    • Hikma did not provide a reason for the shortage.
    • Fresenius Kabi did not provide a reason for the shortage.
Available Products
    • Valproate Sodium injection, Fresenius Kabi, 100 mg/mL, 5 mL vial, 10 count, NDC 63323-0494-05
    • Valproate Sodium injection, Hikma, 100 mg/mL, 5 mL vial, 10 count, NDC 00143-9785-10

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated July 12, 2019 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 29, 2019 by Stephen Andrews, PharmD, BCPS, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer